Path to a Cure (PTAC) - Pilot and Feasibility Award Grant

Path to a Cure (PTAC) - Pilot and Feasibility Award Grant

Status: ACTIVE
Funder: Cystic Fibrosis Foundation
Amount: Up to US $50,000
Last Updated: March 29, 2026

Summary

The Path to a Cure (PTAC) - Pilot and Feasibility Award by the Cystic Fibrosis Foundation aims to support innovative research projects that develop new hypotheses and methods to cure cystic fibrosis. With funding up to $50,000 per year for two years, this award encourages high-risk, high-reward studies focused on CFTR protein function restoration and gene correction approaches. The initiative fosters new investigators in the CF research community, ultimately advancing scientific understanding and therapeutic solutions.

Overview

About the Cystic Fibrosis Foundation The mission of the Cystic Fibrosis Foundation is to cure cystic fibrosis and to provide all people with CF the opportunity to lead long, fulfilling lives by funding research and drug development, partnering with the CF community, and advancing high-quality, specialized care. To achieve this mission, various types of grants and awards are offered to support meritorious research in CF. Path to a Cure (PTAC) - Pilot and Feasibility Award Program and Award Overview Path to a Cure: Pilot and Feasibility Awards are intended to support projects that will develop and test new hypotheses and/or new methods that could eventually contribute to the development of a cure for CF, (or those being applied to the problems of cystic fibrosis for the first time), and to support promising new investigators as they establish themselves in research areas relevant to cystic fibrosis. The intent of these awards is to enable investigators to collect sufficient data to compete successfully for support from the NIH or other funding agencies. Pilot and Feasibility studies that may be high risk but high reward when it comes to advancing our understanding of the disease or developing technologies that can advance us towards a cure are encouraged to apply through this mechanism. Proposals should focus on topics such as restoration of CFTR protein function or approaches to fix/replace the defective CFTR gene. Funding of up to $50,000 per year, plus an additional twelve percent (12%) indirect costs may be requested. Awards may be approved for up to a two (2) year period. Funding for Year 2 is contingent upon submission and approval of a renewal progress report and the availability of funds.

Eligibility

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.